336 related articles for article (PubMed ID: 22922884)
21. Mutations of KRAS and TP53 in a minor proportion of Opisthorchis viverrini-associated cholangiocarcinomas in a hamster model.
Tangkawattana S; Kaewkes S; Pairojkul C; Tangkawattana P; Sripa B
Asian Pac J Cancer Prev; 2008; 9(1):101-6. PubMed ID: 18439086
[TBL] [Abstract][Full Text] [Related]
22. STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression.
Dokduang H; Techasen A; Namwat N; Khuntikeo N; Pairojkul C; Murakami Y; Loilome W; Yongvanit P
J Hepatobiliary Pancreat Sci; 2014 Oct; 21(10):767-76. PubMed ID: 25044480
[TBL] [Abstract][Full Text] [Related]
23. Altered Expression of Oxidative Metabolism Related Genes in Cholangiocarcinomas.
Aukkanimart R; Boonmars T; Juasook A; Sriraj P; Boonjaraspinyo S; Wu Z; Laummuanwai P; Pairojkul C; Khuntikeo N; Rattanasuwan P
Asian Pac J Cancer Prev; 2015; 16(14):5875-81. PubMed ID: 26320466
[TBL] [Abstract][Full Text] [Related]
24. A tumorigenic cell line derived from a hamster cholangiocarcinoma associated with Opisthorchis felineus liver fluke infection.
Mordvinov VA; Minkova GA; Kovner AV; Ponomarev DV; Lvova MN; Zaparina O; Romanenko SA; Shilov AG; Pakharukova MY
Life Sci; 2021 Jul; 277():119494. PubMed ID: 33862109
[TBL] [Abstract][Full Text] [Related]
25. Knockout of liver fluke granulin, Ov-grn-1, impedes malignant transformation during chronic infection with Opisthorchis viverrini.
Chaiyadet S; Tangkawattana S; Smout MJ; Ittiprasert W; Mann VH; Deenonpoe R; Arunsan P; Loukas A; Brindley PJ; Laha T
PLoS Pathog; 2022 Sep; 18(9):e1010839. PubMed ID: 36137145
[TBL] [Abstract][Full Text] [Related]
26. Secreted Opisthorchis viverrini glutathione S-transferase regulates cell proliferation through AKT and ERK pathways in cholangiocarcinoma.
Daorueang D; Thuwajit P; Roitrakul S; Laha T; Kaewkes S; Endo Y; Thuwajit C
Parasitol Int; 2012 Mar; 61(1):155-61. PubMed ID: 21782971
[TBL] [Abstract][Full Text] [Related]
27. A Promising Serum Autoantibody Marker, Anti-Heat Shock Protein 90α, for Cholangiocarcinoma.
Boonjaraspinyo S; Juasook A; Boonmars T; Aukkanimart R; Silsirivanit A; Loilome W; Sriraj P; Wu Z; Ratanasuwan P
Asian Pac J Cancer Prev; 2015; 16(14):5779-85. PubMed ID: 26320451
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of 14-3-3 eta in chronic liver fluke infection is a potential diagnostic marker of cholangiocarcinoma.
Haonon O; Rucksaken R; Pinlaor P; Pairojkul C; Chamgramol Y; Intuyod K; Onsurathum S; Khuntikeo N; Pinlaor S
Proteomics Clin Appl; 2016 Mar; 10(3):248-56. PubMed ID: 26435198
[TBL] [Abstract][Full Text] [Related]
29. Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke
Surapaitoon A; Suttiprapa S; Mairiang E; Khuntikeo N; Pairojkul C; Bethony J; Brindley PJ; Sripa B
Korean J Parasitol; 2017 Jun; 55(3):295-304. PubMed ID: 28719954
[No Abstract] [Full Text] [Related]
30. Plasma checkpoint protein 1 (Chk1) as a potential diagnostic biomarker for opisthorchiasis and cholangiocarcinoma.
Phanaksri T; Yingchutrakul Y; Roytrakul S; Prasopdee S; Kunjantarachot A; Butthongkomvong K; Tesana S; Sathavornmanee T; Thitapakorn V
Cancer Biomark; 2022; 33(1):43-55. PubMed ID: 34366327
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for cholangiocarcinoma in the lower part of Northeast Thailand: a hospital-based case-control study.
Manwong M; Songserm N; Promthet S; Matsuo K
Asian Pac J Cancer Prev; 2013; 14(10):5953-6. PubMed ID: 24289607
[TBL] [Abstract][Full Text] [Related]
32. Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma.
Yongvanit P; Pinlaor S; Loilome W
J Hepatobiliary Pancreat Sci; 2014 May; 21(5):309-15. PubMed ID: 24408859
[TBL] [Abstract][Full Text] [Related]
33. Aberrant expression of NF-κB in liver fluke associated cholangiocarcinoma: implications for targeted therapy.
Seubwai W; Wongkham C; Puapairoj A; Khuntikeo N; Pugkhem A; Hahnvajanawong C; Chaiyagool J; Umezawa K; Okada S; Wongkham S
PLoS One; 2014; 9(8):e106056. PubMed ID: 25170898
[TBL] [Abstract][Full Text] [Related]
34. Cholangiocarcinoma in experimental hamsters with long-standing Opisthorchis viverrini infection.
Songserm N; Prasongwattana J; Sithithaworn P; Sripa B; Pipitkool V
Asian Pac J Cancer Prev; 2009; 10(2):299-302. PubMed ID: 19537899
[TBL] [Abstract][Full Text] [Related]
35. Enhanced neutrophil functions during Opisthorchis viverrini infections and correlation with advanced periductal fibrosis.
Salao K; Spofford EM; Price C; Mairiang E; Suttiprapa S; Wright HL; Sripa B; Edwards SW
Int J Parasitol; 2020 Feb; 50(2):145-152. PubMed ID: 32006550
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance.
Suksawat M; Techasen A; Namwat N; Yongvanit P; Khuntikeo N; Titapun A; Koonmee S; Loilome W
Parasitol Int; 2017 Aug; 66(4):486-493. PubMed ID: 27143607
[TBL] [Abstract][Full Text] [Related]
37. Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance.
Yothaisong S; Namwat N; Yongvanit P; Khuntikeo N; Puapairoj A; Jutabha P; Anzai N; Tassaneeyakul W; Tangsucharit P; Loilome W
Parasitol Int; 2017 Aug; 66(4):471-478. PubMed ID: 26657242
[TBL] [Abstract][Full Text] [Related]
38. Distinct antibody response in susceptible and non-susceptible hosts of the carcinogenic liver fluke
Watakulsin K; Surapaitoon A; Ulag LH; Kaing S; Suyapoh W; Saichua P; Salao K; Tangkawatana S; Suttiprapa S
Parasitology; 2023 Jul; 150(8):653-660. PubMed ID: 37288733
[No Abstract] [Full Text] [Related]
39. Plasma phosphoproteome and differential plasma phosphoproteins with opisthorchis viverrini-related cholangiocarcinoma.
Kotawong K; Thitapakorn V; Roytrakul S; Phaonakrop N; Viyanant V; Na-Bangchang K
Asian Pac J Cancer Prev; 2015; 16(3):1011-8. PubMed ID: 25735322
[TBL] [Abstract][Full Text] [Related]
40. Does a combination of opisthorchiasis and ethyl alcohol consumption enhance early cholangiofibrosis, the risk of cholangiocarcinoma?
Sriraj P; Aukkanimart R; Boonmars T; Juasook A; Sudsarn P; Wonkchalee N; Pairojkul C; Waraasawapati S; Laummaunwai P; Boonjaraspinyo S
Parasitol Res; 2013 Aug; 112(8):2971-81. PubMed ID: 23807659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
